» Articles » PMID: 24019301

SOX12 and NRSN2 Are Candidate Genes for 20p13 Subtelomeric Deletions Associated with Developmental Delay

Overview
Date 2013 Sep 11
PMID 24019301
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

20p13 telomeric/subtelomeric deletions are clinically significant but are currently under-investigated. So far only five molecularly delineated cases have been reported in literature and no candidate genes have been sufficiently implicated. Here, we present six new deletion cases identified by chromosomal microarray analysis (CMA). We also review 32 cases combined from literature and databases. We found that most 20p13 deletion patients exhibit significant developmental delay. Dysmorphic features are common but a consistent pattern was not recognized. Reduced cognitive ability was frequent. Based on pathogenic deletions delineated in this study, we mapped the smallest overlapping region and identified two nervous system expressing genes (SOX12 and NRSN2) as candidate genes that may be involved in the developmental defects in 20p13 microdeletion.

Citing Articles

Alterations of Sensory-related Functional Brain Network Connectivity in Homozygous Knockout Mice.

Yi Y, Dai F, Zhang Y, Han J, Wei J, Wang L Phenomics. 2024; 4(5):473-486.

PMID: 39723223 PMC: 11666851. DOI: 10.1007/s43657-024-00181-x.


Implications of a Variant in the Gene in a Patient with Generalized Epilepsy, Intellectual Disability, and Childhood Emotional Behavioral Disorders.

Treccarichi S, Cali F, Vinci M, Ragalmuto A, Musumeci A, Federico C Curr Issues Mol Biol. 2024; 46(7):6407-6422.

PMID: 39057025 PMC: 11276073. DOI: 10.3390/cimb46070383.


Subtelomeric microdeletion in chromosome 20p13 associated with short stature.

Liu J, Li Y, Andersson H, Upadia J Clin Case Rep. 2024; 12(6):e8927.

PMID: 38863865 PMC: 11164670. DOI: 10.1002/ccr3.8927.


LncRNA LUESCC promotes esophageal squamous cell carcinoma by targeting the miR-6785-5p/NRSN2 axis.

Xue S, Cao S, Ding J, Li W, Hu G, Zheng J Cell Mol Life Sci. 2024; 81(1):121.

PMID: 38457049 PMC: 10924007. DOI: 10.1007/s00018-024-05172-9.


NRSN2 promotes breast cancer metastasis by activating PI3K/AKT/mTOR and NF-κB signaling pathways.

Ren F, Zhang W, Lu S, Ren H, Guo Y Oncol Lett. 2019; 19(1):813-823.

PMID: 31885716 PMC: 6924201. DOI: 10.3892/ol.2019.11152.